BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8707460)

  • 1. Attenuated microvascular perfusion and reactivity in cardiac transplant recipients treated with cyclosporine.
    Andreassen AK; Simonsen S; Bjørnerheim R; Kvernebo K
    Int J Microcirc Clin Exp; 1995; 15(3):117-24. PubMed ID: 8707460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients.
    Andreassen AK; Gullestad L; Holm T; Simonsen S; Kvernebo K
    Clin Transplant; 1998 Aug; 12(4):324-32. PubMed ID: 9686327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation.
    Andreassen AK; Kvernebo K; Jørgensen B; Simonsen S; Kjekshus J; Gullestad L
    Am Heart J; 1998 Aug; 136(2):320-8. PubMed ID: 9704697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heart transplantation on impaired peripheral microvascular perfusion and reactivity in congestive heart failure.
    Andreassen AK; Kirkebøen KA; Gullestad L; Simonsen S; Kvernebo K
    Int J Cardiol; 1998 Jun; 65(1):33-40. PubMed ID: 9699928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients.
    Asberg A; Berg KJ; Hartmann A
    Microvasc Res; 2000 Sep; 60(2):81-90. PubMed ID: 10964582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
    Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
    J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients.
    Andreassen AK; Hartmann A; Offstad J; Geiran O; Kvernebo K; Simonsen S
    J Am Coll Cardiol; 1997 May; 29(6):1324-31. PubMed ID: 9137231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forearm vasorelaxation in hypertensive renal transplant patients: the impact of withdrawal of cyclosporine.
    van den Dorpel MA; van den Meiracker AH; Lameris TW; Weimar W; Man in't Veld AJ
    J Hypertens; 1998 Mar; 16(3):331-7. PubMed ID: 9557926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.
    Zeiher AM; Drexler H; Wollschläger H; Just H
    Circulation; 1991 Nov; 84(5):1984-92. PubMed ID: 1934373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.
    Morris ST; McMurray JJ; Rodger RS; Farmer R; Jardine AG
    Kidney Int; 2000 Mar; 57(3):1100-6. PubMed ID: 10720962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1 R and ecNOS.
    Basset el-EA; Berthoux P; Cécillon S; Deprle C; Thibaudin D; De Filippis JP; Alamartin E; Berthou F
    Clin Nephrol; 2002 Mar; 57(3):192-200. PubMed ID: 11926202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in linear growth and cortisol production between liver and renal transplant recipients on similar immunosuppression.
    Sarna S; Laine J; Sipila I; Koistinen R; Holmberg C
    Transplantation; 1995 Oct; 60(7):656-61. PubMed ID: 7570972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
    Hána V; Prázný M; Marek J; Skrha J; Justová V
    Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension.
    Bracht C; Yan XW; LaRocca HP; Sütsch G; Kiowski W
    J Hypertens; 1999 Mar; 17(3):357-63. PubMed ID: 10100073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
    Sartori TM; Maurizio PG; Sara P; Ugolino L; Annalisa A; Panagiotis T; Massimo F; Antonio G
    J Heart Lung Transplant; 1999 Jul; 18(7):693-700. PubMed ID: 10452346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic stimulation overrides flow-mediated endothelium-dependent epicardial coronary vasodilation in transplant patients.
    Aptecar E; Dupouy P; Benvenuti C; Mazzucotelli JP; Teiger E; Geschwind H; Castaigne A; Loisance D; Dubois-Rande JL
    Circulation; 1996 Nov; 94(10):2542-50. PubMed ID: 8921799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.